Meissa Vaccines Inc — Form D
Meissa Vaccines Inc of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-02. The offering totals $33.9M, of which $13.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-10-02
- Form: D
- Accession: 0001719789-19-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $33.9M
- Amount sold: $13.9M
- Remaining: $20.0M
- Investors: 37
- Date of first sale: 2019-09-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-350196
Issuer
- Name: Meissa Vaccines Inc
- CIK: 0001719789
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 329 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 650-356-0494
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Isaac Cheng | Director | Portland, ME |
| William Daly | Director | South San Francisco, CA |
| Kenneth Kelley | Director | South San Francisco, CA |
| Martin Moore | Director | South San Francisco, CA |
| Stephanie O?Brien | Director | South San Francisco, CA |
| Martin Moore | Executive Officer | South San Francisco, CA |
| Roderick Tang | Executive Officer | South San Francisco, CA |
| Martin Moore | Promoter | South San Francisco, CA |
| Roderick Tang | Director | South San Francisco, CA |
| Roderick Tang | Promoter | South San Francisco, CA |
Other filings by this issuer (1)
More